Description
- The BCL-2 Inhibitor: Clexza works by blocking the BCL-2 protein, a “shield” that cancer cells use to survive, allowing your body to effectively clear them away.
- Oral Convenience: Unlike many IV treatments, Clexza is a once-daily tablet that offers you the flexibility to manage your treatment from the comfort of your home.
- Ramp-Up Safety Protocol: At Shabaha Cancer Centre, we follow a specialized “dose-escalation” schedule to ensure your body adjusts safely to the medication over the first five weeks.
- On-Site Pharmacy Support: Your 100 mg tablets are dispensed directly from our specialized oncology pharmacy, ensuring you always have a reliable supply for your daily regimen.
- Comprehensive Blood Monitoring: During your treatment, Dr. Noordin Bashir Somo and our laboratory team perform regular blood tests to monitor your white cell counts and prevent complications like Tumor Lysis Syndrome (TLS).
